Cargando…

Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells

Detalles Bibliográficos
Autores principales:	Raab, Monika, Pachl, Fiona, Krämer, Andrea, Kurunci-Csacsko, Elisabeth, Dötsch, Christina, Knecht, Rainald, Becker, Sven, Kuster, Bernhard, Strebhardt, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152744/ https://www.ncbi.nlm.nih.gov/pubmed/24980956 http://dx.doi.org/10.1038/cr.2014.86

Ejemplares similares

PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
por: Raab, Monika, et al.
Publicado: (2018)

Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification
por: Gasimli, Khayal, et al.
Publicado: (2022)

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
por: Raab, Monika, et al.
Publicado: (2011)

A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1
por: Raab, Monika, et al.
Publicado: (2021)

Correction: A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1
por: Raab, Monika, et al.
Publicado: (2023)

Immune adaptor SKAP1 acts a scaffold for Polo-like kinase 1 (PLK1) for the optimal cell cycling of T-cells
por: Raab, Monika, et al.
Publicado: (2019)

Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8
por: Helmke, Christina, et al.
Publicado: (2016)

The Prognostic Relevance of the Proliferation Markers Ki-67 and Plk1 in Early-Stage Ovarian Cancer Patients With Serous, Low-Grade Carcinoma Based on mRNA and Protein Expression
por: Rödel, Franz, et al.
Publicado: (2020)

The Role of DAPK1 in the Cell Cycle Regulation of Cervical Cancer Cells and in Response to Topotecan
por: Gasimli, Khayal, et al.
Publicado: (2022)

PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice
por: Zhang, Xiang, et al.
Publicado: (2021)

The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells
por: Raab, Monika, et al.
Publicado: (2021)

Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability
por: Raab, Monika, et al.
Publicado: (2019)

GTPase-activating protein Rasal1 associates with ZAP-70 of the TCR and negatively regulates T-cell tumor immunity
por: Thaker, Youg Raj, et al.
Publicado: (2019)

Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics
por: Noack, Sabrina, et al.
Publicado: (2018)

Immune adaptor protein SKAP1 (SKAP-55) forms homodimers as mediated by the N-terminal region
por: Raab, Monika, et al.
Publicado: (2018)

Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer
por: Kressin, Monika, et al.
Publicado: (2021)

SKAP1 Protein PH Domain Determines RapL Membrane Localization and Rap1 Protein Complex Formation for T Cell Receptor (TCR) Activation of LFA-1
por: Raab, Monika, et al.
Publicado: (2011)

LFA-1 activates focal adhesion kinases FAK1/PYK2 to generate LAT-GRB2-SKAP1 complexes that terminate T-cell conjugate formation
por: Raab, Monika, et al.
Publicado: (2017)

Targeting CDK9 for Anti-Cancer Therapeutics
por: Mandal, Ranadip, et al.
Publicado: (2021)

The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer
por: Mandal, Ranadip, et al.
Publicado: (2022)

Correction: The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer
por: Mandal, Ranadip, et al.
Publicado: (2023)

Identification of the PLK2-Dependent Phosphopeptidome by Quantitative Proteomics
por: Franchin, Cinzia, et al.
Publicado: (2014)

The role of caspase-8 in the tumor microenvironment of ovarian cancer
por: Kostova, Izabela, et al.
Publicado: (2020)

Correction: Identification of the PLK2-Dependent Phosphopeptidome by Quantitative Proteomics
Publicado: (2014)

Reduced mitochondrial mass and function add to age‐related susceptibility toward diet‐induced fatty liver in C57BL/6J mice
por: Lohr, Kerstin, et al.
Publicado: (2016)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023)

Novel Flp pilus biogenesis-dependent natural transformation
por: Angelov, Angel, et al.
Publicado: (2015)

Proteomic identification of novel cytoskeletal proteins associated with TbPLK, an essential regulator of cell morphogenesis in Trypanosoma brucei
por: McAllaster, Michael R., et al.
Publicado: (2015)

Adaptor SKAP-55 Binds p21(ras) Activating Exchange Factor RasGRP1 and Negatively Regulates the p21(ras)-ERK Pathway in T-Cells
por: Schneider, Helga, et al.
Publicado: (2008)

Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells
por: Kerschner-Morales, Sophie L., et al.
Publicado: (2020)

Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck
por: Solbach, Christine, et al.
Publicado: (2006)

Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity
por: Watts, Ellen, et al.
Publicado: (2019)

ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines
por: Dufies, Maeva, et al.
Publicado: (2017)

Targeting Echinococcus multilocularis Stem Cells by Inhibition of the Polo-Like Kinase EmPlk1
por: Schubert, Andreas, et al.
Publicado: (2014)

Asterless amplifies Plk4
por: Short, Ben
Publicado: (2015)

Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
por: Androic, Ilija, et al.
Publicado: (2008)

Liaisons between Survivin and Plk1 during Cell Division and Cell Death
por: Colnaghi, Rita, et al.
Publicado: (2010)

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
por: Busch, Chia-Jung, et al.
Publicado: (2016)

PLK1 contributes to autophagy by regulating MYC stabilization in osteosarcoma cells
por: Mo, Hao, et al.
Publicado: (2019)

Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7dkgm5ri66vckiqfs19524f3tc